FASTR

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFASTR
Drug Alias Namefas-ligand inhibitor (Human Genome Sciences)FASTR
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApoptosis inhibitorsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseaseHepatitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationGraft vs Host DiseaseHepatitis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A